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Results: ELISA test using ESAT-6 peptide (anti-12036)
showed a signiﬁcantly higher sensitivity (100%) than ADA,
LJ medium culture method and ZN staining and PCR tests
(30% ADA, 0% ZN staining, 0% LJ culture and 12.5% PCR) in all
patients (p < 0.001). ADA biochemical test was highly speciﬁc
(100%), followed by anti-12033 test (95.2%). Anti-rESAT-6
showed been lowly sensible and speciﬁc.
Conclusion: In view of the convenience, low cost and high
sensitivity and speciﬁcity, the ELISA tests using a combina-
tion of ESAT-6 peptides could have a promising future in the
diagnosis of childhood tuberculosis.
doi:10.1016/j.ijid.2010.02.413
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Can the nucleic acid ampliﬁcation test (NAT) be an alter-
native to the serologic tests? A prospective study results
of 18,200 blood donors from Turkish Red Crescent
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Birinci 3, K. Kirali 5, A. Aksoy6
1 Istanbul University Cerrahpasa Faculty of Medicine, Istan-
bul, Turkey
2 Istanbul University Cerrahpasa Faculty of Medicine,
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3 Capa, Red Crescent Blood Center, Istanbul, Turkey
4 Istanbul University Istanbul Faculty of Medicine, Istanbul,
Turkey
5 Kosuyolu, Kalp ve Damar Hospital, Istanbul, Turkey
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Background: Serologic tests having high sensitivity and
speciﬁcity are used in order to prevent contamination with
infectious agents from blood and blood products for transfu-
sion safety. Present serologic tests have problems like having
low sensitivity and weak detection capacity of infectious
agents in ‘‘window period’’. We aimed to test the use of NAT
(Nucleic Acid Ampliﬁcation Test) in routine blood screening
in Blood Banking.
Methods: We used Procleix ultrio (Chiron, USA) test kit
based TMA (Transcription Mediated Ampliﬁcation) for NAT
study in serum samples of 18200 donors who were applied to
the Turkish Redcrescent between February 2007-September
2008. The NAT positive samples were studied twice. The dis-
crimination of HIV, HCV and HBV of NAT positive samples
were performed by Procleix Discrimination (Chiron, USA)
test. Otherwise Micro ELISA were used parallely for rou-
tine serological screening of Anti-HIV, Anti-HCV and HBsAg
with Vironoste HIV Uni-form, AG/Ab innotest HCV Ab and
Hepanostica ultra HBsAg test kits.
Results: The results of serum samples with serology(+)
and NAT(+) (13/18200 and 0.05%) for Anti-HIV, Anti-HCV and
HBsAg were detected higher than other NAT studies and we
also detected that a transfusion risk can be occurred in every
1400 transfusions
Conclusion: In this work, we conclude that number of
serologic-negative and NAT positive donors was higher than
those of other studies and viral risk (HBV, HCV) was found
in every 1 of 1400 transfusion. All these were due to high
percentage of ﬁrst time blood donors, nearly all of them
were ﬁrst time donors. If we consider about the high costs
m
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f NAT test compared with the other serologic tests; NAT
as not found to be efﬁcient in all studies on cost-based
ffectiveness. Therefore, NAT should be applicable only for
he ﬁrst time donors at regional blood centers established at
ational level. We conclude that gaining more regular blood
onors are more beneﬁcial for the blood centers.
oi:10.1016/j.ijid.2010.02.414
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omparison of Bactec MGIT 960 and new culture system
ersaTREK for isolation rate, time of detection and and
ontamination rate
. Saribas ∗, P. Yuksel, Y. Bagdatli
Istanbul University, Cerrahpasa Faculty of Medicine, Istan-
ul, Turkey
Background: Mycobacteria Growth Indicator Tube (MGIT)
60 method is a rapid test system which contains liquid
edia to determine mycobacteria culture and drug suscep-
ibility. VersaTREK system contains Middlebrook 7H9 media
ith cellulose sponge and it detects microbial growth by
easuring gas pressure changes in the bottle. We aimed to
ompare the two sytems for incubation time and contami-
ation rate.
Methods: In our study we inoculated various samples of 50
atients, which have been received from Istanbul University
errahpasa Medical Faculty Microbiology Department Tuber-
ulosis Laboratory, into MGIT 960 and VersaTREKmedia. Both
edia compared for Mycobacterium tuberculosis for isola-
ion rate, time of detection and and contamination rate.
Results: Isolation rates for MGIT and VersaTREK were
etected as 4%. Additionally, both systems have been com-
ared for contamination rate and it was found to be 10% for
GIT and 6% for VersaTREK media.
Conclusion: In conclusion, no substantial difference has
een observed between MGIT and VersaTREK media for M.
uberculosis isolation and contamination rate. We suggest
hat VersaTREK media, which is going to be put into use in
urkey, is easy for application and follow up, gives rapid and
ensitive results and that it can be used in routine alike MGIT
edia.
oi:10.1016/j.ijid.2010.02.415
5.016
evelopment of genetic typing method to assign staphy-
ocoagulase (SC) serotype I-X and two SC genotypes for
taphylococcus aureus
. Kobayashi1,∗, S. Ghosh1, M. Hirose2, S.K. Paul3, N.
rushibara1, M. Kawaguchiya1
Sapporo Medical University School of Medicine, Sapporo,
okkaido, Japan
Health Sciences University of Hokkaido, Tobetsu, Japan
Mymensingh Medical College, Mymensingh, BangladeshBackground: Staphylococcus aureus, including
ethicillin-resistant S. aureus, is the most common
athogen of hospital- and community-acquired infections
orldwide. Staphylocoagulase (SC) serotyping is a serologi-
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al classiﬁcation system of S. aureus based on antigenicity
f SC and has been used for a basic epidemiologic typing
ethod for S. aureus. However, some strains have been
ntypeable because of low amount of SC expressed from
acterial cells or presence of putative novel or variant
ypes. Recently, gene sequences of SC deﬁning SC serotypes
-X were determined and divergent portions in SC genes
ere clariﬁed. We found also novel SC genotypes, XI and
II. In the present study, based on the ﬁndings of SC genes,
novel genetic typing of SC (gene) types by PCR assay was
eveloped.
Methods: Two PCR reactions 1 and 2 were designed. In
oth reactions, a common primer which is complementary
o 5′-end conserved region of SC gene is included. Reaction 1
ontains SC serotypes I through VI-speciﬁc primers, and reac-
ion 2 contains SC serotypes VII, VIII, and X-speciﬁc primers.
C serotype-speciﬁc primers were mostly complementary to
1 or D2 region sequences which are divergent among dif-
erent SC serotypes. Depending on the SC serotype, only a
ingle PCR product with the size speciﬁc to each SC serotype
s ampliﬁed in either the reaction 1 or 2. When no product is
mpliﬁed, an additional PCR reaction (reaction 3) is carried
ut to determine SC serotype IX or genotype XI. When type
V was assigned by reaction 1, an additional reaction (reac-
ion 4) is performed to discriminate between SC serotype IV
nd genotype XII.
Results: With the established SC types I-XII S. aureus
trains, a single PCR product with the speciﬁc size to each
ype was ampliﬁed. When 63 S. aureus strains isolated dur-
ng a period between 1993 and 2003 which were untypeable
erologically were tested by this genetic typing method,
bout 90% of the strains were successfully typed. When 117
.aureus strains isolated in 2008 were examined, SC types
ere identiﬁed for 96% of the strains.
Conclusion: The PCR assay established in this study could
ssign SC types for S. aureus accurately with high determina-
ion rate, and was considered to be useful for epidemiologic
haracterization of S. aureus clinical isolates.
oi:10.1016/j.ijid.2010.02.416
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erological diagnosis of lyme disease in Valencia (Spain)
.T. Fraile Farin˜as1,∗, J.L. Ramos Marti 2, N. Tormo Palop2,
. Gimeno Cardona2
Hospital General Universitario de Valencia, Valencia, Spain
CHGUV, Valencia, Spain
Lyme borreliosis (BL) is the tick-borne disease with the
ighest incidence worldwide. Its geographical distribution
hows a pattern of ‘‘endemic areas’’, where infected Ixodes
icinus in enough density to have an epidemiological impact.
n Spain, it is a low incidence process although the prob-
ems inherent in their clinical and laboratory diagnosis are
robably due to an underdiagnosis. Studies are needed to
upplement information on the distribution of the etiologic
gent in different areas of our country, which are not con-
idered endemic but where their presence is suspected.
Methods: From 1 January 2008 to August 31, 2009, 1422
amples were analyzed in patients from the inﬂuence area
f the Valencia University General Hospital with clinical
a
2
tternational Congress on Infectious Diseases (ICID) Abstracts
uspicion of BL. As a screening test, we used an enzyme
mmunoassay that uses chemiluminescence technology (Dia
orin Borrelia IgG) for the quantitative determination of
gG antibodies. We used as a conﬁrmatory test the Western
lot (European Borrelia plus Virotech), considering positive
ndings, the presence of at least two bands of the follow-
ng: p83/100, BmpA (p39), Ospc (p23), DbpA or vice-Mix
Mix. Indeterminate results were considered in the pres-
nce of a band; p83/100, BmpA (p39), OspC (p23), DbpA
r vice-Mix-Mix. In all samples detection of antibodies to
reponema pallidum was performed. Positive results were
ound by the screening test in 137 samples (9.63%), corre-
ponding to 105 patients. The Western blot showed positive
esults in 39 samples of 28 patients, indeterminate in 16
amples from 12 patients and negative in 82 samples. The
9 positive samples were from patients (28) from the ser-
ices of Neurology N = 16, Internal Medicine N = 13, N = 6,
= 4 Dermatology and Psychiatry. Luetic serology were neg-
tive in all samples. In 8 patients administered ceftriaxone
mg/día for three weeks with good clinical and serological
urvey.
Conclusion: Our diagnostic methods, show a group of
atients with speciﬁc characteristics and clinical outcome,
nd support the existence of probable cases of Lyme borre-
iosis. Screening methods have high sensitivity but are not
ery speciﬁc, because only 28 (26.6%) of 105 patients tested
ositive by Western blot.
oi:10.1016/j.ijid.2010.02.417
5.018
ulticenter evaluation of Ziehl-Neelsen bleach sed-
mentation method for diagnosis of smear negative
uberculosis in Kenya
. Matu ∗, L. Muita, E. Juma
Kenya Medical Research Institute, Nairobi, Kenya
Background: World Health Organization (WHO) recom-
ends direct smear microscopy using Ziehl-Neelsen (ZN)
echnique for tuberculosis (TB) case ﬁnding in resource poor
ettings. This method has a low sensitivity. Bleach methods
ave been shown to increase sensitivity in some settings.
owever, no evaluation has been carried out in settings
here TB burden is high and improved diagnosis is desper-
tely needed.
Objective: To evaluate the ZN bleach sedimentation
echnique for diagnosis of smear negative tuberculosis in
eripheral canters.
Methods: 1122 direct ZN smear negative sputum spec-
mens from new TB suspects attending three peripheral
ealth centers in Nairobi were collected. At each cen-
er, sputum specimens were homogenized then divided into
wo equal portions. One portion was processed for cul-
ure. The other portion was treated with 3.5% bleach. The
reated specimens were kept at room temperature and left
vernight for at least 15 hours. Smears were prepared from
he deposit and examined using ZN method.Results: Of the 1112 smear negative specimens, 968 were
nalyzed. Of these, 84(8.7%) were culture positive.Of these,
3 (27.3%) were both culture and smear positive. The sensi-
ivity was (27.4%) and speciﬁcity of (98.4%) with a PPV and
